THERAPEUTIC POTENTIAL OF DUAL PI3K DELTA/GAMMA INHIBITION IN T-CELL LYMPHOMAS

被引：0
|
作者：
Vakkalanka, S. [1 ]
Viswanadha, S. [2 ]
Govindarajulu, B. [3 ]
Prasanna, R. [4 ,5 ]
Veeraraghavan, S.
Nagarathnam, D. [6 ]
机构：
[1] Rhizen Pharmaceut SA, Gen Adm, La Chaux De Fonds, Switzerland
[2] Incozen Therapeut Pvt Ltd, Drug Discovery, Hyderabad, Telangana, India
[3] Incozen Therapeut Pvt Ltd, Med Chem, Hyderabad, Telangana, India
[4] Incozen Therapeut Pvt Ltd, Biol Res, Hyderabad, Telangana, India
[5] Incozen Therapeut Pvt Ltd, Pharmacokinet, Hyderabad, Telangana, India
[6] DNSK Int, Chem, Hamden, CT USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P985
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [21] EXPRESSION OF THE ALPHA-BETA AND GAMMA-DELTA T-CELL RECEPTORS IN 57 CASES OF PERIPHERAL T-CELL LYMPHOMAS - IDENTIFICATION OF A SUBSET OF GAMMA-DELTA T-CELL LYMPHOMAS
    GAULARD, P
    BOURQUELOT, P
    KANAVAROS, P
    HAIOUN, C
    LECOUEDIC, JP
    DIVINE, M
    GOOSSENS, M
    ZAFRANI, ES
    FARCET, JP
    REYES, F
    AMERICAN JOURNAL OF PATHOLOGY, 1990, 137 (03): : 617 - 628
  • [22] Evaluation of the PI3K pathway in peripheral t-cell lymphoma
    Lim, S. T.
    Nairismagi, M-L.
    Tan, S. H.
    Thit, E. E.
    Politz, O.
    Liu, N.
    Ong, C. K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Therapeutic Utility of PI3Kγ Inhibition in Leukemogenesis and Tumor Cell Survival
    Diacovo, Thomas
    Whye, Dosh
    Efimenko, Evgeni
    Chen, Jianchung
    Tosello, Valeria
    De Keersmaecker, Kim
    Kashishian, Adam
    Thompson, Mary Ann
    Castillo, Mireia
    Cordon-Cardo, Carlos
    Dave, Utpal P.
    Ferrando, Adolfo A.
    Lannutti, Brian J.
    Subramaniam, Prem
    BLOOD, 2012, 120 (21)
  • [24] PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
    Silveira, Andre Bortolini
    Albertoni Laranjeira, Angelo Brunelli
    Libanio Rodrigues, Gisele Olinto
    Leal, Paulo Cesar
    Cardoso, Bruno Antonio
    Barata, Joao Taborda
    Yunes, Rosendo Augusto
    Tonin Zanchin, Nilson Ivo
    Brandalise, Silvia Regina
    Yunes, Jose Andres
    ONCOTARGET, 2015, 6 (15) : 13105 - 13118
  • [25] The Novel Role of PI3K Delta Inhibition in Both T and B Cell Activation in Alloimmunity.
    Azzi, J.
    Mounayar, M.
    Magee, C.
    Abdi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 250 - 250
  • [26] PI3K: A potential therapeutic target for cancer
    Chen, Yingwei
    Wang, Bao-Can
    Xiao, Yongtao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (07) : 2818 - 2821
  • [27] A dual PI3K/mTOR inhibitor as potential therapeutic option for vulvar cancer
    Rodrigues, Lara
    Rodrigues, Bruna
    Giudice, Fernanda
    Baiocchi, Glauco
    Soares, Fernando Augusto
    Martins, Vilma
    Rocha, Rafael Malagoli
    CANCER RESEARCH, 2015, 75
  • [28] Two Atypical Cases of Cutaneous Gamma/Delta T-Cell Lymphomas
    Caudron, A.
    Bouaziz, J. D.
    Battistella, M.
    Sibon, D.
    Lok, C.
    Leclech, C.
    Ortonne, N.
    Molinier-Frenkel, V.
    Bagot, M.
    DERMATOLOGY, 2011, 222 (04) : 297 - 303
  • [29] Inhibition of PI3K as a potential treatment for cancer
    Zuluaga, S.
    Suarez-Fueyo, A.
    Carrera, A. C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 61 - 61
  • [30] PI3K-inhibition increases apoptotic priming in T-cell lymphomas and synergizes with BH3 mimetics
    Koch, R.
    Nothnick, G.
    Becker, S.
    Truemper, L.
    Wulf, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 23 - 24
12345